ALLUMINOX PALETTE
Live / Applied — Fourth extension granted (statement of use) (as of 03 Nov 2025)
What this means for you
Not registered yet, but its 13 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97589806
- Mark type
- Design + words
- Filed
- 13 Sept 2022
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Gina Durham, Esq.
Goods and services
- Class 041 — Education and entertainment services: Educational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; providing training in the oncology field; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing
- Class 042 — Scientific and technological services: Scientific, biological, and medical research; conducting clinical trials for others for the purpose of advancing knowledge and developing new approaches; providing prescription scientific drug research information by means of providing links to third party websites relating to cancer drugs; Providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer related to prevention and treatment; providing medical information services in the field of treating cancer; Providing online information services, namely, prescription drug medical information; Providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing an Internet website featuring medical information and articles about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and medical information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing healthcare information regarding cancer drugs and cancer treatment; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing
Owner
- Rakuten Medical, Inc., San Diego, CA, US
- Rakuten Medical, Inc., San Diego, CA, US
Prosecution history
- 04 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2025 — SOU EXTENSION 4 GRANTED
- 03 Nov 2025 — SOU EXTENSION 4 FILED
- 03 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jun 2025 — SOU EXTENSION 3 GRANTED
- 25 Jun 2025 — SOU EXTENSION 3 FILED
- 25 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2024 — SOU EXTENSION 2 GRANTED
- 16 Dec 2024 — SOU EXTENSION 2 FILED
- 16 Dec 2024 — SOU TEAS EXTENSION RECEIVED